Premium
Kura Oncology Inc (KURA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. Brian T. PowlChief Commercial Officer | -10,00k | 110,00k | Automatic Disposition | 11,00 | 56,98k | -14,93% |
| 2026-05-19 | Ms. Kathleen FordCOO | -2,26k | 20,48k | Automatic Disposition | 9,08 | 103,56k | -2,13% |
| 2026-05-19 | Mr. Brian T. PowlChief Commercial Officer | -339,00 | 3,12k | Automatic Disposition | 9,21 | 66,98k | -0,50% |
| 2026-05-18 | Ms. Teresa Brophy BairChief Legal Officer & Corporate Secretary | -2,26k | 21,16k | Automatic Disposition | 9,38 | 113,34k | -1,95% |
| 2026-03-23 | Dr. Troy Edward WilsonChairman, CEO & President | 6,10k | 37,53k | Derivative Exercise and Retained Stock | 6,15 | 832,15k | 0,74% |
| 2026-03-18 | Mr. Thomas R. MalleyIndependent Director | 10,00k | 31,20k | Derivative Exercise and Retained Stock | 3,12 | 10,00k | - |
| 2026-01-27 | Mr. Thomas DoyleSVP of Finance & Accounting | -7,14k | 60,43k | Vente | 8,46 | 79,26k | -8,27% |
| 2026-01-27 | Mr. Brian T. PowlChief Commercial Officer | -6,41k | 54,27k | Vente | 8,46 | 66,64k | -8,78% |
| 2026-01-27 | Dr. Francis J. BurrowsChief Scientific Officer | -1,31k | 11,09k | Vente | 8,46 | 32,42k | -3,89% |
| 2026-01-27 | Ms. Teresa Brophy BairChief Legal Officer & Corporate Secretary | -11,21k | 94,83k | Vente | 8,46 | 113,34k | -9,00% |
| 2026-01-27 | Dr. Mollie LeoniChief Medical Officer | -8,18k | 69,21k | Vente | 8,46 | 167,43k | -4,66% |
| 2026-01-27 | Ms. Kathleen FordCOO | -1,81k | 15,34k | Vente | 8,46 | 103,56k | -1,72% |
| 2025-12-18 | Dr. Francis J. BurrowsChief Scientific Officer | 11,27k | 54,12k | Derivative Exercise and Retained Stock | 4,80 | 30,61k | 58,31% |
| 2025-12-18 | Dr. Francis J. BurrowsChief Scientific Officer | -23,73k | 118,05k | Derivative Exercise and Sale | 4,80 - 9,78 | 30,61k | - |
| 2025-12-09 | Mr. Faheem HasnainLead Independent Director | -10,00k | 109,76k | Automatic Disposition | 10,98 | 23,98k | -29,43% |
| 2025-11-14 | Ms. Kathleen FordCOO | -6,90k | 77,14k | Vente | 11,18 | 99,90k | -6,46% |
| 2025-11-14 | Ms. Teresa Brophy BairChief Legal Officer & Corporate Secretary | -8,80k | 98,40k | Vente | 11,18 | 95,64k | -8,43% |
| 2025-11-14 | Dr. Mollie LeoniChief Medical Officer | -15,49k | 173,07k | Vente | 11,18 | 151,39k | -9,28% |
| 2025-11-14 | Mr. Thomas DoyleSVP of Finance & Accounting | -4,54k | 50,73k | Vente | 11,18 | 63,26k | -6,70% |
| 2025-11-14 | Mr. Brian T. PowlChief Commercial Officer | -8,89k | 99,33k | Vente | 11,18 | 57,74k | -13,34% |
| 2025-09-29 | Ms. Teresa Brophy BairChief Legal Officer & Corporate Secretary | -8,81k | 78,74k | Vente | 8,94 | 55,54k | -13,68% |
| 2025-09-29 | Ms. Kathleen FordCOO | -6,89k | 61,63k | Vente | 8,94 | 57,90k | -10,64% |
| 2025-09-29 | Dr. Mollie LeoniChief Medical Officer | -12,31k | 110,11k | Vente | 8,94 | 84,38k | -12,74% |
| 2025-09-29 | Dr. Troy Edward WilsonChairman, CEO & President | -36,62k | 327,42k | Vente | 8,94 | 826,05k | -4,24% |
| 2025-09-29 | Mr. Brian T. PowlChief Commercial Officer | -8,89k | 79,51k | Vente | 8,94 | 42,18k | -17,41% |
| 2025-09-29 | Mr. Thomas DoyleSVP of Finance & Accounting | -4,54k | 40,61k | Vente | 8,94 | 42,83k | -9,59% |
| 2025-09-08 | Dr. Troy Edward WilsonChairman, CEO & President | 50,00k | 410,15k | Achat | 8,20 | 680,16k | 7,93% |
| 2025-08-12 | Dr. Troy Edward WilsonChairman, CEO & President | 50,00k | 303,20k | Achat | 5,85 - 6,64 | 630,16k | 8,62% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
